Dopo l'orario di chiusura: 64.76 0.18 +0.28%

Gilead Sciences, Inc. (GILD)

Gilead Sciences, Inc. Borsa (GILD) Ultime notizie

Gilead Sciences, Inc. (GILD)

Gilead Sciences, Inc. Borsa (GILD) Ultime notizie

The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine

Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It

Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat

Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript

Gilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say

Gilead Sciences (GILD) Reports Q1 Loss, Tops Revenue Estimates

Stocks Drop, Tech Tumbles With Meta's Weak Outlook, Q1 Stagflation Fears; Gold Miners Advance: What's Driving Markets Thursday?

Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields

US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst

What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?

Incyte (INCY) Earnings Expected to Grow: Should You Buy?

Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?

Insights Into Gilead (GILD) Q1: Wall Street Projections for Key Metrics

Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week

Gilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know

The Analyst Verdict: Gilead Sciences In The Eyes Of 12 Experts

Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for

Pfizer's Doldrums, Just A Bad Case Of COVID-19?

Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why

Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know

Better Growth Play: Merck or The Vanguard Growth Index Fund?

Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?

Should You Invest in the VanEck Biotech ETF (BBH)?

Gilead Sciences (GILD) Stock Moves -0.84%: What You Should Know

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter

Gilead Sciences (GILD) Exceeds Market Returns: Some Facts to Consider

3 No-Brainer Dividend Stocks to Buy in April

Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It

Gilead Sciences (GILD) Dips More Than Broader Market: What You Should Know

Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress: Analyst

Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields

U.S. Wide-Moat Stocks On Sale - The March 2024 Heat Map

Gilead Sciences (GILD) Stock Moves -0.04%: What You Should Know

Why Is Axsome (AXSM) Down 4% Since Last Earnings Report?

Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know

Gilead Sciences (GILD) Rises But Trails Market: What Investors Should Know

2 Top Dividend Stocks to Buy Hand Over Fist

Bristol Myers Squibb cell therapy gets FDA green light to treat common type of leukemia

Gilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know

3 Dividend Stocks to Buy Hand Over Fist in March

The AI Race Gets Litigious

Why Gilead Sciences (GILD) Outpaced the Stock Market Today

Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley

Why Is Gilead (GILD) Down 2.4% Since Last Earnings Report?

Gilead (GILD) & MRK's HIV Oral Combo Shows Efficacy in Phase II

Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock

Rare Stock Picks In February 2024 - From 32 Discerning Analysts

Simile a GILD